Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats

Journal of Hypertension

Volumn 19, Issue 10, 2001, Pages 1827-1833

  Raasch, Walter ^a   Betge, Stefan ^a   Dendorfer, Andreas ^a   Bartels, Torsten ^a   Dominiak, Peter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Adrenaline; Angiotensin converting enzyme inhibitors; Heart; Hypertension; Noradrenaline; Spontaneously hypertensive rat; Uptake 1

Indexed keywords

DESIPRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; FOSINOPRILAT;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART MUSCLE METABOLISM; HORMONE RELEASE; HYPERTENSION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE;

EID: 0034816119     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200110000-00017     Document Type: Article

References (50)

1. Bjorn Folkow Award Lecture. The sympathetic nervous system in hypertension
2. Modulation of noradrenaline release in the pithed rabbit. A role for angiotensin II
3. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors
4. 3H-noradrenaline uptake in cat mesenteric blood vessels
5. Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs
6. Hormones regurating cardiovascular function in patients with severe congestive heart failure and their relation to mortality CONSENSUS Trial Study Group
7. Myocardial catecholamine concentrations in dilated cardiomyopathy and heart failure of different origins
8. Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamberspecific contributor to beta-adrenoceptor downregulation
9. 123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure
10. ACE inhibition improves cardiac NE uptake and attenuates sympathetic nerve terminal abnormalities in heart failure
11. Sympathetic activation in the pathogenesis of hypertension and progression of organ damage
12. Chamber-specific alterations of norepinephrine uptake sites in cardiac hypertrophy
13. Changes in cardiac norepinephrine in spontaneously hypertensive and stroke-prone rats
14. The effects of captopril on blood pressure in essential hypertensive patients with low or normal plasma renin activity. Interference with autonomic nervous system
15. Cardiac and hormonal effects of enalapril in hypertension
16. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension
17. Converting enzyme inhibition with an orally active compound in hypertensive man
18. Biosynthesis of catecholamines and sympathetic outflow in spontaneously hypertensive rats (SHR) after chronic treatment with CE blocking agents
19. Effects of chronic treatment with ramipril, a new ACE blocking agent, on presynaptic sympathetic nervous system of SHR
20. Modulation of sympathetic control by ACE inhibitors
21. ACE inhibitors (ACEI) increase tissue catechoalamines without affecting monoamine oxidase (MAO)
22. An intramolecularly quenched fluorescent tripeptide as a fluorogenic substrate of angiotensin-l-converting enzyme and of bacterial dipeptidyl carboxypeptidase
23. Extraadrenal adrenaline formation by two separate enzymes
24. Nonadrenal epinephrine-forming enzymes in humans. Characteristics, distribution, regulation, and relationship to epinephrine levels
25. Similarities of genetic (spontaneous) hypertension. Man and rat
26. Cardiac norepinephrine, beta-adrenoceptors, and Gi alpha-proteins in prehypertensive, hypertensive spontaneously hypertensive rats
27. Adrenaline in cardiovascular diseases-effect of beta-adrenoceptor antagonists
28. Cardiac function and morphology with aging in the spontaneously hypertensive rat
29. The contractile state as the major determinant in the evolution of left ventricular dysfunction in the spontaneously hypertensive rat
30. Ontogenetic aspects of hypertension development: Analysis in the rat
31. Chronic ACE-inhibitor treatment and adrenergic mechanisms in spontaneously hypertensive rats
32. Acetylcholine and norepinephrine concentrations in the heart of spontaneously hypertensive rats: A parasympathetic role in hypertension
33. Differential structural reaponses of small resistance vessels to antihypertensive therapy
34. Effect of converting enzyme inhibitor (SQ14 225) on myocardial hypertrophy in spontaneously hypertensive rats
35. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats
36. Long-term inhibition of NO synthase induces cardiac hypertrophy with a decrease in adrenergic innervation
37. Cardioprotective effects of ACE inhibitors: Experimental proof and clinical perspectives
38. Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: Beyond blood pressure reduction
39. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors
40. Characterization of bradykinin receptors mediating catecholamine release in PC12 cells
41. 2 receptor
42. Comparative effects of bradykinin and atrial natriuretic factor on neuronal and non-neuronal noradrenaline uptake in the central nervous system of the rat
43. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves
44. 6-NO(2)-norepinephrine increases norepinephrine release and inhibits norepinephrine uptake in rat spinal synaptosomes
45. Regulation of norepinephrine transport system by angiotensin II in neuronal cultures of normotensive and spontaneously hypertensive rat brains
46. The effects of norepinephrine on myocardial biology: Implications for the therapy of heart failure
47. Spectral analysis of heart rate variability in evaluation of sympathetic function in elderly subjects
48. Power spectral analysis of the heart rate in hypertensive patients with and without left ventricular hypertrophy: The effect of a left ventricular mass reduction
49. Plasma noradrenaline as an index of sympathetic tone in coronary arterial disease: The confounding influence of clearance of noradrenaline
50. Plasma norepinephrine increased during coronary occlusion in hypertensive pigs that developed ventricular fibrillation